# 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

> **NCT01247285** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Fluoxetine Hydrochloride
- **DRUG:** PROZAC WEEKLY®

## Key facts

- **NCT ID:** NCT01247285
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2001-07
- **Final completion:** 2001-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2011-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247285, "90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01247285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*